Marielle Morissens

Dr. Marielle Morissens

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in International Journal of Cardiology
Verified
Journal Article
Closed access
CGCharlien Gabriels
Charlien Gabriels
PMPieter De Meester
Pieter De Meester
APAgnes Pasquet
Agnes Pasquet
JBJulie De Backer
Julie De Backer
BPBernard Paelinck
Bernard Paelinck
WBWerner Budts
Werner Budts

22 November 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
GBGeorgiana Pintea Bentea
Georgiana Pintea Bentea
BBBrahim Berdaoui
Brahim Berdaoui
MMMarielle Morissens
Marielle Morissens
PBPhilippe van de Borne
Philippe van de Borne
JRJosé Castro Rodriguez
José Castro Rodriguez
Atrial fibrillation (AF) and coronary artery disease are frequently associated and, when so, lead to a grim prognosis. Recent studies suggest the presence of interconnected pathophysiological pathways between the 2 conditions that can promote and aggravate each other, igniting a vicious cycle. Notwithstanding, in contrast with the attention dedicated to the management of antithrombotic treatment, research on other aspects of coronary artery disease in AF is only recently gaining traction. The clinical impact of correct assessment of coronary artery stenosis in AF is especially high, due to the antithrombotic therapy imposed by both AF and coronary stenting. Until recently, an in‐depth characterization of coronary microcirculation in AF was lacking. However, contemporary studies indicate that coronary microvascular dysfunction is a frequent encounter in AF, possibly explaining the ischemic symptoms even in the absence of obstructive coronary artery disease and interfering with the use of pressure‐based indices to evaluate the hemodynamic significance of coronary artery stenosis. This comprehensive review addresses our current knowledge on coronary physiology in AF and its repercussion on the invasive management of coronary artery disease in this setting.

31 January 2005 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
TVThierry Verbeet
Thierry Verbeet
JCJosé Castro
José Castro
MMMarielle Morissens
Marielle Morissens
ENEmmanuel T. Ngoc
Emmanuel T. Ngoc
Pierre DecoodtPierre Decoodt
Pierre Decoodt

1 January 2022 in The American Journal of Cardiology
Verified
Journal Article
Closed access
GBGeorgiana Pintea Bentea
Georgiana Pintea Bentea
BBBrahim Berdaoui
Brahim Berdaoui
SSSophie Samyn
Sophie Samyn
MMMarielle Morissens
Marielle Morissens
JRJosé Castro Rodriguez
José Castro Rodriguez

6 April 2022 in Journal of Translational Internal Medicine
Verified
Journal Article
Open access
PDF file
HSHugo Steyaert
Hugo Steyaert
JRJose Castro Rodriguez
Jose Castro Rodriguez
MGMarie-Dominique Gazagnes
Marie-Dominique Gazagnes
MMMarielle Morissens
Marielle Morissens
Cryptogenic strokes can be defined by the criteria established for an embolic stroke of undetermined source (ESUS). Some embolic events might be caused by a left atrial septal pouch (LASP), due to the potential of thrombus formation. In this study we aimed to determine if LASP is a risk factor for ESUS when compared to a population of strokes of known origin, the LASP screening rate in our institution and if LASP dimensions influences the risk of ESUS. We retrospectively analyzed transesophageal echocardiograms (TEEs) in a large cohort of patients that had experienced ischemic strokes. Two authors performed blinded, independent searches for LASPs by reviewing 1152 TEEs from patients that had experienced a stroke or transient ischemic attack. We excluded 26 TEEs, due to incorrect imaging. Next, we reviewed patient medical files. Among the 1126 included patients, 148 had an ESUS (ESUS+ group) and 978 had strokes of known origin (ESUS– group). A LASP was present in 176 patients, including 32 patients (21.6% of LASPs) in the ESUS+ group and 144 patients (14.7% of LASPs) in the ESUS– group. In multivariate analysis, LASP was independently associated with ESUS (P = 0,019). 61.9% of LASPs that we found were not mentioned in reports from the original TEE operators. This study demonstrated that LASPs were more prevalent in patients with ESUS than in patients with strokes of known origin. Our results gave rise to the question of whether anticoagulation would be appropriate for some patients with ESUS. New large-scale, prospective studies should be conducted to address this issue. Additionally, considering the low rate of LASP descriptions, we concluded that the awareness of operators should be raised to improve their success in identifying LASPs.

5 July 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
Pierre DecoodtPierre Decoodt
Pierre Decoodt
DSDaniel Sierra-Sosa
Daniel Sierra-Sosa
LALaura Anghel
Laura Anghel
GCGiovanni Cuminetti
Giovanni Cuminetti
EKEva De Keyzer
Eva De Keyzer
MMMarielle Morissens
Marielle Morissens
Identifying patients with left ventricular ejection fraction (EF), either reduced [EF < 40% (rEF)], mid-range [EF 40–50% (mEF)], or preserved [EF > 50% (pEF)], is considered of primary clinical importance. An end-to-end video classification using AutoML in Google Vertex AI was applied to echocardiographic recordings. Datasets balanced by majority undersampling, each corresponding to one out of three possible classifications, were obtained from the Standford EchoNet-Dynamic repository. A train–test split of 75/25 was applied. A binary video classification of rEF vs. not rEF demonstrated good performance (test dataset: ROC AUC score 0.939, accuracy 0.863, sensitivity 0.894, specificity 0.831, positive predicting value 0.842). A second binary classification of not pEF vs. pEF was slightly less performing (test dataset: ROC AUC score 0.917, accuracy 0.829, sensitivity 0.761, specificity 0.891, positive predicting value 0.888). A ternary classification was also explored, and lower performance was observed, mainly for the mEF class. A non-AutoML PyTorch implementation in open access confirmed the feasibility of our approach. With this proof of concept, end-to-end video classification based on transfer learning to categorize EF merits consideration for further evaluation in prospective clinical studies.